Indegene, a company in the Healthcare Research, Analytics & Technology industry, reported revenue of ₹1,122 crore and net profit of ₹112 crore for the September 2026 quarter.
Indegene (NSE: INDGN) closed at ₹657.65 on 20 Nov 2026, up 27.7% over the past year. Its market capitalisation is ₹15,849 crore and it trades at 37.2 times earnings.
Incorporated in 1998, Indegene Ltd provides solutions consisting of analytics, technology and commercial, medical, regulatory and safety services to life science and health care organizations
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.